Advancing Structural Characterization of Therapeutic Proteins with Microfluidic Modulation Spectroscopy

Existing tools for measuring and monitoring the structure of biotherapeutic molecules during formulation have had until now very significant limitations in sensitivity and have been very difficult to use. In this webinar, Amgen shares data that demonstrates the power of Microfluidic Modulation Spectroscopy (MMS), a valuable, fully-automated IR technology, to generate high-quality, reproducible secondary structure data for protein therapeutics, including monoclonal antibodies.

  • Free

Why attend?


Select a speaker to learn more